Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jesse Schold and Susana Arrigain.

 
Connection Strength
 
 
 
3.347
 
  1. Amdani S, Boyle G, Rossano J, Scheel J, Richmond M, Arrigain S, Schold JD. Association of low center performance evaluations and pediatric heart transplant center behavior in the United States. J Heart Lung Transplant. 2021 08; 40(8):831-840.
    View in: PubMed
    Score: 0.203
  2. Poggio ED, Augustine JJ, Arrigain S, Brennan DC, Schold JD. Long-term kidney transplant graft survival-Making progress when most needed. Am J Transplant. 2021 08; 21(8):2824-2832.
    View in: PubMed
    Score: 0.200
  3. Tsuang WM, Arrigain S, Lopez R, Snair M, Budev M, Schold JD. Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study. Transplantation. 2020 11; 104(11):2365-2372.
    View in: PubMed
    Score: 0.196
  4. Tsuang WM, Arrigain S, Lopez R, Budev M, Schold JD. Lung transplant waitlist outcomes in the United States and patient travel distance. Am J Transplant. 2021 01; 21(1):272-280.
    View in: PubMed
    Score: 0.193
  5. Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED. Dramatic secular changes in prognosis for kidney transplant candidates in the United States. Am J Transplant. 2019 02; 19(2):414-424.
    View in: PubMed
    Score: 0.168
  6. Augustine JJ, Arrigain S, Balabhadrapatruni K, Desai N, Schold JD. Significantly Lower Rates of Kidney Transplantation among Candidates Listed with the Veterans Administration: A National and Local Comparison. J Am Soc Nephrol. 2018 10; 29(10):2574-2582.
    View in: PubMed
    Score: 0.167
  7. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21.
    View in: PubMed
    Score: 0.144
  8. Navaneethan SD, Kirwan JP, Arrigain S, Schold JD. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol. 2014 Jul 08; 15:108.
    View in: PubMed
    Score: 0.127
  9. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sarnak MJ, Schold JD. Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol. 2012; 36(3):219-27.
    View in: PubMed
    Score: 0.111
  10. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504.
    View in: PubMed
    Score: 0.099
  11. Bilen Y, Schold JD, Arrigain S, Buchalter RB, Huml AM. Relationship of Social Deprivation Among Living Kidney Donor-Recipient Pairs. Transplant Direct. 2024 Jan; 10(1):e1559.
    View in: PubMed
    Score: 0.061
  12. Augustine JJ, Liaqat A, Arrigain S, Schold JD, Poggio ED. Performance of estimated glomerular filtration rate equations in Black living kidney donor candidates. Clin Transplant. 2024 Jan; 38(1):e15198.
    View in: PubMed
    Score: 0.061
  13. Lehr CJ, Schold JD, Arrigain S, Valapour M. New OPTN/UNOS data demonstrates higher than previously reported waitlist mortality for lung transplant candidates supported with ECMO. J Heart Lung Transplant. 2023 10; 42(10):1399-1407.
    View in: PubMed
    Score: 0.058
  14. Fadel R, Taliercio JJ, Daou R, Layoun H, Bassil E, Fawaz A, Arrigain S, Schold JD, Herlitz L, Simon JF, Mehdi A, Nakhoul G. Urine Sediment Examination: Comparison Between Laboratory-Performed Versus Nephrologist-Performed Microscopy and Accuracy in Predicting Pathologic Diagnosis in Patients with Acute Kidney Injury. Kidney360. 2023 07 01; 4(7):918-923.
    View in: PubMed
    Score: 0.058
  15. Cholin LK, Schold JD, Arrigain S, Poggio ED, Sedor JR, O'Toole JF, Augustine JJ, Wee AC, Huml AM. Characteristics of Potential and Actual Living Kidney Donors: A Single-center Experience. Transplantation. 2023 04 01; 107(4):941-951.
    View in: PubMed
    Score: 0.057
  16. Hassanein M, Arrigain S, Schold JD, Nakhoul GN, Navaneethan SD, Mehdi A, Sekar A, Tabbara J, Taliercio JJ. Dysnatremias, Mortality, and Kidney Failure in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Kidney Med. 2022 Dec; 4(12):100554.
    View in: PubMed
    Score: 0.056
  17. Cholin L, Ashour T, Mehdi A, Taliercio JJ, Daou R, Arrigain S, Schold JD, Thomas G, Nally J, Nakhoul NL, Nakhoul GN. Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression. BMC Nephrol. 2021 07 15; 22(1):264.
    View in: PubMed
    Score: 0.052
  18. Nakhoul GN, Mehdi A, Taliercio JJ, Arrigain S, Schold JD, Spencer A, Greenfield J, Diwakar A, Snyder G, O'Toole J, Nally JV, Sedor JR, Kao PF, Bierer SB. "What do you think about nephrology?" A national survey of internal medicine residents. BMC Nephrol. 2021 05 21; 22(1):190.
    View in: PubMed
    Score: 0.051
  19. Augustine JJ, Arrigain S, Mandelbrot DA, Schold JD, Poggio ED. Factors Associated With Residual Kidney Function and Proteinuria After Living Kidney Donation in the United States. Transplantation. 2021 02 01; 105(2):372-381.
    View in: PubMed
    Score: 0.050
  20. Navaneethan SD, Kirwan JP, Remer EM, Schneider E, Addeman B, Arrigain S, Horwitz E, Fink JC, Lash JP, McKenzie CA, Rahman M, Rao PS, Schold JD, Shafi T, Taliercio JJ, Townsend RR, Feldman HI. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55.
    View in: PubMed
    Score: 0.048
  21. Click B, Lopez R, Arrigain S, Schold J, Regueiro M, Rizk M. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 07 17; 26(8):1268-1275.
    View in: PubMed
    Score: 0.048
  22. Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S, Schold JD, Vachharajani T, Nally J, Nakhoul GN. Correction to: Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020 Apr 17; 21(1):139.
    View in: PubMed
    Score: 0.047
  23. Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S, Schold JD, Vachharajani T, Nally J, Na Khoul GN. Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020 02 12; 21(1):49.
    View in: PubMed
    Score: 0.047
  24. Lehr CJ, Lopez R, Arrigain S, Schold J, Koval C, Valapour M. The impact of change in definition of increased-risk donors on survival after lung transplant. J Thorac Cardiovasc Surg. 2020 Aug; 160(2):572-581.
    View in: PubMed
    Score: 0.046
  25. Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease. J Am Heart Assoc. 2019 02 05; 8(3):e009980.
    View in: PubMed
    Score: 0.044
  26. Saeed F, Arrigain S, Schold JD, Nally JV, Navaneethan SD. What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104.
    View in: PubMed
    Score: 0.043
  27. Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV, Nakhoul GN. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron. 2019; 141(1):31-40.
    View in: PubMed
    Score: 0.043
  28. Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV, Navaneethan SD. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
    View in: PubMed
    Score: 0.042
  29. Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
    View in: PubMed
    Score: 0.041
  30. Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322.
    View in: PubMed
    Score: 0.040
  31. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427.
    View in: PubMed
    Score: 0.039
  32. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281.
    View in: PubMed
    Score: 0.039
  33. Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1204-1210.
    View in: PubMed
    Score: 0.039
  34. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV. Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
    View in: PubMed
    Score: 0.038
  35. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46.
    View in: PubMed
    Score: 0.035
  36. Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82.
    View in: PubMed
    Score: 0.035
  37. Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV, Navaneethan SD. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63.
    View in: PubMed
    Score: 0.034
  38. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27.
    View in: PubMed
    Score: 0.034
  39. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8.
    View in: PubMed
    Score: 0.034
  40. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20.
    View in: PubMed
    Score: 0.034
  41. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015 May 03; 16:69.
    View in: PubMed
    Score: 0.034
  42. Liu F, Bennett S, Arrigain S, Schold J, Heyka R, McLennan G, Navaneethan SD. Patency and Complications of Translumbar Dialysis Catheters. Semin Dial. 2015 Jul-Aug; 28(4):E41-7.
    View in: PubMed
    Score: 0.033
  43. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25.
    View in: PubMed
    Score: 0.032
  44. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74.
    View in: PubMed
    Score: 0.031
  45. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV. Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol. 2014; 39(4):288-96.
    View in: PubMed
    Score: 0.031
  46. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63.
    View in: PubMed
    Score: 0.031
  47. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.031
  48. Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10.
    View in: PubMed
    Score: 0.029
  49. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52.
    View in: PubMed
    Score: 0.029
  50. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Sarnak MJ, Nally JV. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34.
    View in: PubMed
    Score: 0.027
  51. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402.
    View in: PubMed
    Score: 0.026
  52. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Simon JF, Srinivas TR, Nally JV. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43.
    View in: PubMed
    Score: 0.026
  53. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ, Jain A, Nally JV. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol. 2011 Jan; 6(1):40-9.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)